Poland· PL-100285896
Tardyferon-Fol
A ferrous sulfate and folic acid product containing ferrosi sulfas + acidum folicum, registered in Poland by Delfarma Sp. z o.o.. The same ATC class is registered in 4 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Ferrous sulfate and folic acid is registered in 4 of 19 countries.
Countries holding a registration under ATC B03AD03 (ferrous sulfate and folic acid), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 3 of them publish a price we can compare per daily dose
Ferrous sulfate and folic acid · ATC B03AD03
4 / 19 countries
- Czechiaprice
- Ireland
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of ferrous sulfate and folic acid costs, country by country.
Normalised to the WHO defined daily dose (0.1 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ferrous sulfate and folic acid · price per daily dose (0.1 g)
USD · FX 28 Sept 2026
- CH Switzerland$0.36
The record
At a glance
URPL (Poland)- Active substance
- Ferrosi sulfas + Acidum folicum
- Manufacturer
- Delfarma Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- B03AD03
- ATC class
- Ferrous sulfate and folic acid
- Defined daily dose
- 0.1 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909997212272
- gtin05909997212289
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
10 interactions on record for ferrous sulfate and folic acid.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ferrous sulfate and folic acid · interactions on record
10 records
10 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Ferrous sulfate and folic acid in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomFefol SpansulesEsteve Pharmaceuticals Ltd
- SpainBIALFER 90 mg + 1 mg COMPRIMIDOS RECUBIERTOS CON PELICULALaboratorios Bial S.A.
- FranceTARDYFERON B9, comprimé pelliculéPIERRE FABRE MEDICAMENT
- IrelandFerrograd Folic 325mg/0.35mg Prolonged release TabletsTeofarma S.R.L.
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Austria · Ferrograd – Fol
- Greece · Fero-Folic
- Hungary · Ferrograd Folic
- Portugal · Ferrograd Fólico
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cd8f24f1-bae4-46f0-b701-4b98b404e329 GET /v1/drugs/cd8f24f1-bae4-46f0-b701-4b98b404e329?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki o przedłużonym uwalnianiu",
"source": "urpl",
"strength": "80 mg Fe2+ + 0,35 mg",
"packaging": "05909997212272 ¦ Rp ¦ 78985\n30 tabl.\n05909997212289 ¦ Rp ¦ 79121\n100 tabl.",
"substance": "Ferrosi sulfas 80 mg Fe2+ + Acidum folicum 0.35 mg",
"common_name": "Ferrosi sulfas + Acidum folicum",
"pl_product_id": "100285896",
"pozwolenie_nr": "437/12",
"auth_procedure": "IR",
"authorisation_validity": "2027-07-30"
}See everything about ferrous sulfate and folic acid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.